This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
European Biotech Acquisition Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 3/6
Wichtige Informationen
0%
Verhältnis von Schulden zu Eigenkapital
US$0
Verschuldung
| Zinsdeckungsgrad | n/a |
| Bargeld | US$272.63k |
| Eigenkapital | -US$6.04m |
| Gesamtverbindlichkeiten | US$134.75m |
| Gesamtvermögen | US$128.70m |
Jüngste Berichte zur Finanzlage
Recent updates
Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: EBAC has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Langfristige Verbindlichkeiten: EBAC has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: EBAC is debt free.
Schulden abbauen: EBAC's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Schuldendeckung: EBAC has no debt, therefore it does not need to be covered by operating cash flow.
Zinsdeckung: EBAC has no debt, therefore coverage of interest payments is not a concern.